(Q24597261)

1

0 references

J Kaburaki

2

0 references

Y Okano

3

0 references

H Inoko

4

0 references

K Tsuji

Journal of Clinical Investigation

5

0 references

language of work or name

English

0 references

publication date

September 1993

0 references

published in

0 references

volume

92

0 references

issue

3

0 references

page(s)

1296-301

0 references

cites work

Characterisation of centromere (kinetochore) antigen reactive with sera of patients with a scleroderma variant (CREST syndrome)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288271

Interaction between a "processed" ovalbumin peptide and Ia molecules

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288271

Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288271

A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288271

Determination of an epitope of the diffuse systemic sclerosis marker antigen DNA topoisomerase I: sequence similarity with retroviral p30gag protein suggests a possible cause for autoimmunity in systemic sclerosis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288271

Association of polar amino acids at position 26 of the HLA-DQB1 first domain with the anticentromere autoantibody response in systemic sclerosis (scleroderma)

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288271

Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis)

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288271

The association of HLA-B8 with visceral disease in systemic sclerosis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288271

Association of HLA antigen a9 with progressive systemic sclerosis (scleroderma).

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288271

Association between an HLA haplotype and low responsiveness to tetanus toxoid in man.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288271

Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288271

Systemic sclerosis (scleroderma): clinical, genetic, and serologic subsets.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288271

Clinical associations of anticentromere antibodies and antibodies to topoisomerase I. A study of 355 patients

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288271

HLA-DRB1 genotyping by modified PCR-RFLP method combined with group-specific primers

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288271

A recombinant topoisomerase I used for autoantibody detection in sera from patients with systemic sclerosis

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=288271

Increased frequency of HLA-DR5 in scleroderma

30 May 2018

1 reference

12 December 2020

The CREST syndrome: a distinct serologic entity with anticentromere antibodies

1 reference

12 December 2020

Increased frequency of B8/DR3 in scleroderma and association of the haplotype with impaired cellular immune response

1 reference

12 December 2020

HLA antigens and scleroderma

1 reference

12 December 2020

HLA-D Antigens in Progressive Systemic Sclerosis (Scleroderma)

1 reference

12 December 2020

Lack of association of HLA-DR antigens with progressive systemic sclerosis (scleroderma)

1 reference

12 December 2020

Histocompatibility antigens in progressive systemic sclerosis (PSS; scleroderma)

1 reference

12 December 2020

Suppressor T cells control the HLA-linked low responsiveness to streptococcal antigen in man

1 reference

12 December 2020

HLA-DR antigens in progressive systemic sclerosis (scleroderma)

1 reference

12 December 2020

The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases. A marker for a subset of polymyositis with interstitial pulmonary fibrosis

1 reference

12 December 2020

Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis

1 reference

12 December 2020

Scleroderma: possible significance of silent alleles at the C4B locus

1 reference

12 December 2020

HLA antigens, autoantibodies and clinical subsets in scleroderma

1 reference

12 December 2020

Binding of immunogenic peptides to Ia histocompatibility molecules

1 reference

12 December 2020

DR antigens in systemic sclerosis: lack of clinical correlations

1 reference

12 December 2020

HLA-DQ is epistatic to HLA-DR in controlling the immune response to schistosomal antigen in humans

1 reference

12 December 2020

DNA-DR typing shows HLA-DRw11 RFLPs are increased in frequency in both progressive systemic sclerosis and CREST variants of scleroderma

1 reference

12 December 2020

A simple and rapid method for HLA-DRB and -DQB typing by digestion of PCR-amplified DNA with allele specific restriction endonucleases

1 reference

12 December 2020

Immunogenetic associations of scleroderma-related antinuclear antibodies

1 reference

12 December 2020

Use of molecular cloning methods to map the distribution of epitopes on topoisomerase I (Scl-70) recognized by sera of scleroderma patients

1 reference

12 December 2020

HLA-DQ-restricted CD4+ T cells specific to streptococcal antigen present in low but not in high responders

1 reference

12 December 2020

An antigenic region of topoisomerase I in DNA polymerase chain reaction-generated fragments recognized by autoantibodies of scleroderma patients

1 reference

12 December 2020

HLA-DQB1 genotyping by a modified PCR-RFLP method combined with group-specific primers

1 reference

12 December 2020

Modified PCR-RFLP method for HLA-DPB1 and -DQA1 genotyping

1 reference

12 December 2020

Strong and unique associations of HLA-DPB1 alleles with other HLA antigens in a Japanese population

1 reference

12 December 2020

Southern hybridization analysis of DNA polymorphism in the HLA-D region

1 reference

12 December 2020

Histocompatibility antigens in progressive systemic sclerosis (scleroderma)

1 reference

12 December 2020

A strong association between null alleles at the C4A locus in the major histocompatibility complex and systemic sclerosis

1 reference

12 December 2020

Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome

1 reference

12 December 2020

An HLA-linked immune suppression gene in man

1 reference

12 December 2020

Increased prevalence of DRw3 in the CREST syndrome

1 reference

12 December 2020